Literature DB >> 30415128

Mesenteric vascular and nerve sparing surgery in laparoscopic segmental intestinal resection for deep infiltrating endometriosis.

Ricciarda Raffaelli1, Simone Garzon2, Silvia Baggio1, Michele Genna3, Paola Pomini1, Antonio Simone Laganà4, Fabio Ghezzi4, Massimo Franchi1.   

Abstract

OBJECTIVE(S): To investigate Mesenteric vascular and nerve Sparing Surgery (MSS) as surgical laparoscopic technique to perform segmental intestinal resection for deep infiltrating endometriosis (DIE). STUDY
DESIGN: Prospective cohort study between January 2013 and December 2016. Consecutive patients with suspected intestinal DIE underwent clinical and imaging evaluation to confirm intestinal involvement. Indications for radical surgery and surgical technique (intestinal resection versus shaving) were consistent with Abrão algorithm. Surgeons aimed to perform MSS in all the consecutive patients that required intestinal resection. MSS consists in mesenteric artery, branching arteries, and surrounding nerve fibers preservation by dissecting mesentery adherent to the intestinal wall. Data about history, preoperative and post-operative evaluation, surgery and complications were recorded. Symptoms were evaluated before and 30-60 days after surgery with numeric rating scale for pain. Constipation was evaluated with the Constipation Assessment Scale (CAS). Patients with diagnosis of irritable bowel syndrome, inflammatory bowel diseases, diverticulitis, and previous segmental intestinal resection were excluded.
RESULTS: Sixty-two out of 75 (82.7%) consecutive women with intestinal endometriosis underwent laparoscopic segmental intestinal resection performed with MSS. Major complications that required repeated operation occurred in 4 cases (6.5%). Anastomotic leakage occurred in only 1 case (1.6%). Dysmenorrhea (p < .001; r = -0.86), dyspareunia (p < .001; r = -0.80), dyschezia (p < .001; r = -0.86) and dysuria (p < .001; r = -0.56) were significantly improved after surgery. After an average of 33.1 months from surgery, severe constipation was reported only by two patients (3.6%) (CAS: 13-16). The median time from surgery to intestinal function recovery (flatus or stool passage) was one day. Logistic regression analysis showed constipation related to the distance from anal verge and time since surgery. CONCLUSION(S): MSS in laparoscopic intestinal resection for DIE may be reproducible, safe and effective. MSS could be combined with pelvic nerve-sparing surgery as an effective approach to improve intestinal symptoms after radical surgery for DIE that requires segmental intestinal resection.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Constipation; Deep infiltrating endometriosis; Nerve-sparing surgery; Segmental intestinal resection; Vascular-sparing surgery

Mesh:

Year:  2018        PMID: 30415128     DOI: 10.1016/j.ejogrb.2018.10.057

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  21 in total

1.  Uterine manipulator in total laparoscopic hysterectomy: safety and usefulness.

Authors:  Yara Abdel Khalek; Roger Bitar; Costas Christoforou; Simone Garzon; Alessandro Tropea; Antonio Biondi; Zaki Sleiman
Journal:  Updates Surg       Date:  2019-10-12

2.  Net survival of patients with colorectal cancer: a comparison of two periods.

Authors:  Zdravko Štor; Rok Blagus; Alessandro Tropea; Antonio Biondi
Journal:  Updates Surg       Date:  2019-06-12

3.  Anogenital Distance and Endometriosis: Results of a Case-Control Study.

Authors:  Laura Buggio; Edgardo Somigliana; Greta Sergenti; Federica Ottolini; Dhouha Dridi; Paolo Vercellini
Journal:  Reprod Sci       Date:  2022-07-11       Impact factor: 2.924

4.  Factors Affecting the Postoperative Bowel Function and Recurrence of Surgery for Intestinal Deep Endometriosis.

Authors:  Ping Xu; Jianzhang Wang; Yanan Zhang; Libo Zhu; Xinmei Zhang
Journal:  Front Surg       Date:  2022-06-14

5.  Diagnosis and Treatment of Endometriosis and Endometriosis-Associated Infertility: Novel Approaches to an Old Problem.

Authors:  Antonio Simone Laganà; Amerigo Vitagliano; Vito Chiantera; Ettore Cicinelli
Journal:  J Clin Med       Date:  2022-07-05       Impact factor: 4.964

6.  Anastrozole and levonorgrestrel-releasing intrauterine device in the treatment of endometriosis: a randomized clinical trial.

Authors:  Pedro Acién; Irene Velasco; Maribel Acién
Journal:  BMC Womens Health       Date:  2021-05-20       Impact factor: 2.809

7.  National trends in inpatient endometriosis admissions: Patients, procedures and outcomes, 2006-2015.

Authors:  Stephanie J Estes; Ahmed M Soliman; Andrew J Epstein; Julia C Bond; Keith Gordon; Stacey A Missmer
Journal:  PLoS One       Date:  2019-09-19       Impact factor: 3.240

8.  Reductions in endometriosis-associated pain among women treated with elagolix are consistent across a range of baseline characteristics reflective of real-world patients.

Authors:  Mauricio S Abrao; Eric Surrey; Keith Gordon; Michael C Snabes; Hui Wang; Horia Ijacu; Hugh S Taylor
Journal:  BMC Womens Health       Date:  2021-06-16       Impact factor: 2.809

9.  Couples with mild male factor infertility and at least 3 failed previous IVF attempts may benefit from laparoscopic investigation regarding assisted reproduction outcome.

Authors:  Agni Pantou; Konstantinos Sfakianoudis; Evangelos Maziotis; Polina Giannelou; Sokratis Grigoriadis; Petroula Tsioulou; Georgia Kokkali; Michael Koutsilieris; Konstantinos Pantos; Mara Simopoulou
Journal:  Sci Rep       Date:  2020-02-11       Impact factor: 4.379

10.  Dye diffusion during laparoscopic tubal patency tests may suggest a lymphatic contribution to dissemination in endometriosis: A prospective, observational study.

Authors:  Marco Scioscia; Anna Pesci; Arnaldo Scardapane; Marco Noventa; Gloria Bonaccorsi; Pantaleo Greco; Giuseppe Zamboni
Journal:  PLoS One       Date:  2019-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.